The program will be a source of revenue for GoodRx, and might also open a new fee stream for CVS’ pharmacy benefit manager as the drug middlemen face increased scrutiny for complex pricing models.
The program will be a source of revenue for GoodRx, and might also open a new fee stream for CVS’ pharmacy benefit manager as the drug middlemen face increased scrutiny for complex pricing models.